指南与共识系统性红斑狼疮

专家意见是否符合狼疮低疾病活动状态的定义?来自西班牙多中心队列500例患者的前瞻性分析

Does expert opinion match the definition of lupus low disease activity state? Prospective analysis of 500 patients from a Spanish multicentre cohort.
指南 / 共识 · Rheumatology (Oxford) · 2023-01-01

该研究在西班牙多中心前瞻性队列中对508例系统性红斑狼疮(SLE)患者应用狼疮低疾病活动状态(LLDAS)定义,并与医生主观评估的活动性进行一致性分析。结果显示304例(62.7%)处于LLDAS,医生评估430例(86.1%)为缓解或低活动,两者总体一致率71.4%(95%CI:70.1,70.5),Cohen's κ为0.3(IQR 0.22-0.37)。LLDAS与医生评估仅呈中等一致性,LLDAS达标者一致率更高,作者据此认为应将LLDAS作为达标治疗目标。

要点

  • 508例SLE患者中304例(62.7%)符合LLDAS,医生评估430例(86.1%)为缓解或低活动。
  • LLDAS与医生评估总体一致率71.4%(95%CI:70.1,70.5),Cohen's κ为0.3(IQR 0.22-0.37)。
  • 未达LLDAS者中126例(70.4%)被医生判为缓解或低活动,主要因新发表现及SLEDAI 2K>4分。

核心结论

  • 近三分之二SLE患者处于LLDAS,LLDAS与医生评估之间一致性尚可,达标者一致性更好;作者认为应将LLDAS作为达标治疗目标。

研究设计与样本

  • 西班牙多中心前瞻性研究的横断面分析,纳入508例SLE患者,应用LLDAS定义并评估其与医生主观活动性判断的一致性。

主要发现

  • 508例患者中92%为女性,平均年龄50.4岁(s.d. 3.7),304例(62.7%)符合LLDAS。
  • 医生评估430例(86.1%)为缓解或低活动,与LLDAS总体一致率71.4%(95%CI:70.1,70.5),Cohen's κ为0.3(IQR 0.22-0.37)。
  • LLDAS达标者中96.1%被专家判为缓解或低活动,未达LLDAS者中126例(70.4%)被判为缓解或低活动。
  • 不一致的主要原因包括与上次访视相比出现新发表现以及SLEDAI 2K评分>4分(主要基于血清学活动)。

关键数值与推荐

  • LLDAS与医生评估总体一致率71.4%(95%CI:70.1,70.5),Cohen's κ为0.3(IQR 0.22-0.37)。
  • 304例(62.7%)符合LLDAS,430例(86.1%)被医生评估为缓解或低活动。
  • LLDAS达标者中96.1%被专家判为缓解或低活动;未达LLDAS者中126例(70.4%)被判为缓解或低活动。

临床怎么用

  • 作者认为,鉴于LLDAS与医生评估在定义低活动上存在不一致、LLDAS与更好结局相关且比医生意见更严格,应将LLDAS作为达标治疗目标。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To apply the lupus low disease activity state (LLDAS) definition within a large cohort of patients and to assess the agreement between the LLDAS and the physician's subjective evaluation of lupus activity. METHODS: We conducted a cross-sectional analysis of a prospective multicentre study of SLE patients. We applied the LLDAS and assessed whether there was agreement with the clinical status according to the physician's opinion. RESULTS: A total of 508 patients [92% women; mean age 50.4 years (s.d. 3.7)] were recruited and 304 (62.7%) patients were in the LLDAS. According to physician assessment, 430 (86.1%) patients were classified as remission or low activity. Overall agreement between both evaluations was 71.4% (95% CI: 70.1, 70.5) with a Cohen's κ of 0.3 [interquartile range (IQR) 0.22-0.37]. Most cases (96.1%) in the LLDAS were classified as remission or low activity by the expert. Of the patients who did not fulfil the LLDAS, 126 (70.4%) were classified as having remission/low disease activity. The main reasons for these discrepancies were the presence of new manifestations compared with the previous visit and a SLEDAI 2K score >4, mainly based on serological activity. CONCLUSIONS: Almost two-thirds of SLE patients were in the LLDAS. There was a fair correlation between the LLDAS and the physician's evaluation. This agreement improves for patients fulfilling the LLDAS criteria. The discordance between both at defining lupus low activity, the demonstrated association of the LLDAS with better outcomes and the fact that the LLDAS is more stringent than the physician's opinion imply that we should use the LLDAS as a treat-to-target goal.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Altabás-González I, Rúa-Figueroa I, Rubiño F, et al. Does expert opinion match the definition of lupus low disease activity state? Prospective analysis of 500 patients from a Spanish multicentre cohort. Rheumatology (Oxford). 2023. PMID: 35961050. doi:10.1093/rheumatology/keac462

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。